Home / Opportunities / Opportunity
PROCUREMENT OPPORTUNITY

Framework for the Provision of Dose Banded Products & Patient Specific Chemotherapy Services

University Hospitals of Derby and Burton NHS Foundation Trust · Preliminary market engagement notice on Find a Tender

Tender information last checkedLast checked 8 Oct 2026, 08:10.

Opportunity overview

The East Midlands Pharmacy Collaborative (EMPC) as the Authority wishes to establish a multi-provider Framework Agreement for its members the Dose Banded Products & Patient Specific Chemotherapy Services as defined in this specification. This procurement exercise is being carried out as an Open Procedure under the PA23 Regulations. The Framework will run for an initial 2 Year period with an option to extend for a further 2 Years. (2 + 2 - maximum duration 4 Years) This a new PME notice published due to changes in the Procurement Timetable. The previous notice was published on 12th May 2025 under 2025/S 000-020394.

Classification

  • CPV33600000 — Pharmaceutical products

Lots

  • Lot 1Value not stated

Documents and notices

Published notice details

Additional information from the published procurement release. Fields appear only when supplied by the source; check the original notice and tender documents before acting.

Scope, procedure and submissions

Id
D100
Main Procurement Category
goods
Above Threshold
Yes
Status
planning

Legal basis

Id
2023/54
Scheme
UKPGA

Techniques

Has Framework Agreement
Yes

Communication

Future Notice Date
11 Jan 2027, 23:59

Lots and requirements

Entry 1
Id
1
Has Renewal
Yes
Status
planning

Suitability

Sme
Yes

Contract period

Starts
1 Sept 2027, 00:00
Ends
31 Aug 2029, 23:59
Max Extent Date
31 Aug 2031, 23:59

Items and delivery

Item 1
Id
1
Related Lot
1

Additional Classifications

Entry 1
Scheme
CPV
Id
33600000
Description
Pharmaceutical products

Planning and budget

Milestones

Entry 1
Id
engagement
Type
engagement
Description
The East Midlands Pharmacy Collaborative (EMPC) wishes to notify the market of a further Prior Market Engagement (PME) event in relation to the forthcoming procurement for Dose Banded Chemotherapy Products and Patient Specific Services. The original PME notice was published on the Find a Tender Service on 12 May 2025 (Notice Identifier: 2025/S 000-020394). Since publication of that notice, the proposed procurement timetable has changed and the Authority is undertaking a further market engagement exercise to provide an update to the market. The purpose of the PME meeting is to: Inform suppliers of the revised procurement timetable; Discuss the draft specification; Discuss the proposed commercial schedule; and Provide suppliers with an opportunity to ask questions and provide feedback. The meeting will be held via Microsoft Teams on Thursday 19th November 2026 at 10:00 a.m. All interested suppliers are invited to attend, regardless of whether they participated in the previous PME exercise. Suppliers wishing to attend should register their interest by contacting Jane Brailsford at jane.brailsford1@nhs.net. A Teams invite will be sent out.
Due
19 Nov 2026, 23:59
Status
scheduled

Documents

Entry 1
Id
094865-2026
Document Type
marketEngagementNotice
Notice Type
UK2
Description
Preliminary market engagement notice on Find a Tender
Published
7 Oct 2026, 15:25
Format
text/html

Buyer, suppliers and contacts

Organisation 1
Name
University Hospitals of Derby and Burton NHS Foundation Trust
Id
GB-PPON-PQZD-7532-NDHL

Identifier

Scheme
GB-PPON
Id
PQZD-7532-NDHL

Address

Street Address
Royal Derby Hospital, Uttoxeter Road 
Locality
Derby
Postal Code
DE22 3NE
Country
GB
Country Name
United Kingdom
Region
UKF11

Contact

Name
Jane Brailsford

Roles

buyer

Details

Classifications

Entry 1
Scheme
UK_CA_TYPE
Id
publicAuthorityCentralGovernment
Description
Public authority - central government

Recorded locations

  • Buyer location · Derby · UKF11 · DE22 3NE · United Kingdom

Notice and amendment history

1 published notice version reviewed by ProcuraAxis.

1 VERSION
  1. 094865-2026Preliminary market engagement notice on Find a Tender ·

PROCURAAXIS ANALYSIS

ProcuraAxis Analysis

Our approved analysis of the opportunity appears below the official tender information.

ANALYSIS PREVIEW

Opportunity intelligence at a glance

Early-stage market engagement for a planned multi-provider framework supplying dose-banded products and patient-specific chemotherapy services to East Midlands Pharmacy Collaborative members. The intended framework is expected to run for 2 years with an optional 2-year extension.

Who this may suit

Potential fit for suppliers of pharmaceutical products, dose-banded chemotherapy products and patient-specific chemotherapy services. Bidding is not stated to be open.

Key points identified

  • Required scopeDose-banded products and patient-specific chemotherapy servicesEvidence: "Framework for the Provision of Dose Banded Products & Patient Specific Chemotherapy Services" and description states the framework is for these services.
  • Framework modelMulti-provider framework agreementEvidence: "wishes to establish a multi-provider Framework Agreement".
  • Buyer/authorityEast Midlands Pharmacy Collaborative (EMPC), with University Hospitals of Derby and Burton NHS Foundation Trust named as buyerEvidence: Description names EMPC as the Authority; buyer_name is University Hospitals of Derby and Burton NHS Foundation Trust.
94% approved-analysis confidence4 supplier criteria identified3 risks or unknowns

SOURCE AND FRESHNESS

Traceable procurement data

Source
Find a Tender
Notice reference
094865-2026
OCID
ocds-h6vhtk-078301
First published
7 Oct 2026
Last checked
8 Oct 2026, 08:10
Notice versions reviewed
1

HOW THIS WAS PREPARED

Approved, evidence-bound analysis

ProcuraAxis structures information found in published procurement records, checks the result for consistency and publishes only approved analysis. Confidence describes the completeness and consistency of the available source information; it is not a guarantee of eligibility or contract award.

Analysis status
Approved for publication
Analysed
8 Oct 2026
Read the analysis methodology →